These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Current role of the automatic implantable cardioverter-defibrillator in the treatment of life-threatening ventricular arrhythmias. Kay GN; Plumb VJ; Dailey SM; Epstein AE Am J Med; 1990 Jan; 88(1N):25N-34N. PubMed ID: 2195882 [TBL] [Abstract][Full Text] [Related]
5. New approaches to management of arrhythmias after myocardial infarction. Curtis AB; Mansour M Cardiovasc Clin; 1989; 20(1):259-81. PubMed ID: 2653637 [TBL] [Abstract][Full Text] [Related]
7. Current clinical perspectives on antiarrhythmic drug therapy. Anderson JL Fed Proc; 1986 Jul; 45(8):2213-9. PubMed ID: 3720963 [TBL] [Abstract][Full Text] [Related]
8. [The principles of pharmacotherapy for arrhythmia at the turn of the millenium]. Fazekas T; Liszkai G Orv Hetil; 1999 Dec; 140(51):2851-9. PubMed ID: 10647274 [TBL] [Abstract][Full Text] [Related]
9. Post automatic implantable cardioverter defibrillator implant therapies: drugs and ablative techniques. Colella A; Pieragnoli P; Ricciardi G; Giaccardi M; Padeletti L; Michelucci A Minerva Cardioangiol; 2007 Jun; 55(3):341-51. PubMed ID: 17534253 [TBL] [Abstract][Full Text] [Related]
11. A focus on when and when not to use antiarrhythmic drugs in treating ventricular arrhythmias and indications for the use of automatic implantable cardioverter-defibrillators. Aronow WS Geriatrics; 2008 Aug; 63(8):20-8. PubMed ID: 18672953 [TBL] [Abstract][Full Text] [Related]
12. [Prevention of cardiac arrhythmias: what is the place for antiarrhythmic drugs?]. Probst V; Trochu JN; Le Marec H Rev Prat; 2004 Feb; 54(3):286-90. PubMed ID: 15134235 [TBL] [Abstract][Full Text] [Related]
13. [Maternal cardiac arrhythmias in pregnancy]. Facchini M; Bauersfeld U; Fasnacht M; Candinas R Schweiz Med Wochenschr; 2000 Dec; 130(51-52):1962-9. PubMed ID: 11688063 [TBL] [Abstract][Full Text] [Related]
14. [Clinical proarrhythmias induced by anti-arrhythmic drugs, non-cardiovascular agents and implantable cardioverter-defibrillators]. Fazekas T; Liszkai G Orv Hetil; 2002 Jan; 143(2):61-9. PubMed ID: 11868450 [TBL] [Abstract][Full Text] [Related]
15. Beta-blocking agents vs. antiarrhythmic interventions in heart failure complicated by arrhythmias. Meinertz T; Hofmann T; Zehender M; Drexler H; Hohnloser S; Just H J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S151-7. PubMed ID: 11527120 [TBL] [Abstract][Full Text] [Related]
16. Progress in arrhythmia therapy. Rodman J; Benditt D Clin Pharm; 1983; 2(4):307-11. PubMed ID: 6883960 [TBL] [Abstract][Full Text] [Related]
18. [Possibilities and limitations of treatment for arrhythmia]. Lüderitz B Z Gesamte Inn Med; 1991 Aug; 46(12):425-30. PubMed ID: 1950023 [TBL] [Abstract][Full Text] [Related]
19. Cardiac arrhythmias: the quest for a cure: a historical perspective. Wellens HJ J Am Coll Cardiol; 2004 Sep; 44(6):1155-63. PubMed ID: 15364313 [TBL] [Abstract][Full Text] [Related]